The endometrial ablation devices market size has grown strongly in recent years. It will grow from $3.87 billion in 2025 to $4.14 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing prevalence of abnormal uterine bleeding, expansion of gynecological care services, rising adoption of minimally invasive procedures, availability of advanced ablation technologies, growing patient awareness of treatment options.
The endometrial ablation devices market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing preference for outpatient gynecological procedures, rising adoption of next-generation ablation devices, expansion of single-use medical technologies, growing focus on faster recovery treatments, increasing investments in women’s health solutions. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of radiofrequency endometrial ablation devices, growing demand for outpatient treatment options, expansion of single-use ablation technologies, enhanced focus on procedure safety and efficiency.
The rising prevalence of gynecological disorders is expected to drive the growth of the endometrial ablation devices market in the coming years. Gynecological disorders are medical conditions that affect the female reproductive system and include menstrual disorders, endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, pelvic inflammatory disease (PID), and ovarian cysts, among others. Endometrial ablation devices are used to treat these conditions by removing or destroying the uterine lining (endometrium), helping to reduce or stop heavy menstrual bleeding and manage conditions such as adenomyosis and endometrial hyperplasia. For example, in June 2023, the World Health Organization, a Switzerland-based specialized health agency dedicated to global public health, reported that PCOS affects 8-13% of women of reproductive age, with up to 70% of affected women remaining undiagnosed worldwide. Consequently, the increasing prevalence of gynecological disorders is fueling the growth of the endometrial ablation devices market.
The increasing healthcare spending is expected to drive the growth of the endometrial ablation devices market in the coming years. Healthcare expenditure refers to the total amount of financial resources allocated to healthcare services, products, and infrastructure within a specific country, region, or organization. Effective and targeted healthcare spending enhances the connectivity, safety, and overall efficiency of endometrial ablation procedures, leading to improved outcomes for women with gynecological conditions. For example, in May 2023, according to the Office for National Statistics, a UK-based government department, healthcare spending in the UK reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2022. Therefore, the rising healthcare spending is driving the growth of the endometrial ablation devices market.
Key players in the endometrial ablation devices market are also working on developing advanced solutions like field ablation systems to improve efficacy and patient comfort. A field ablation system is a medical device used to treat abnormal tissue, particularly in the heart, by applying energy (such as radiofrequency, laser, or cryotherapy) to a specific area. For instance, in January 2024, Abbott Laboratories, a US-based medical device company, launched its Volt Pulsed Field Ablation (PFA) System, marking the beginning of human trials aimed at treating atrial fibrillation (AFib). This cutting-edge technology uses pulsed field energy to selectively target heart muscle cells, minimizing collateral damage to surrounding tissues compared to traditional thermal ablation techniques. The system features a balloon-in-basket catheter design for greater precision and stability, and integrates with the EnSite X cardiac mapping platform to improve procedural accuracy. Initial trials are being conducted in Australia, with plans for global expansion, positioning Abbott as a leader in AFib treatment as demand for advanced therapies grows.
Major companies operating in the endometrial ablation devices market are Hologic Inc., Medtronic plc, Boston Scientific Corporation, Olympus Corporation, The Cooper Companies Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Richard Wolf GmbH, B. Braun Melsungen AG, Minerva Surgical Inc., AEGEA Medical Inc., Channel Medsystems Inc., Lina Medical ApS, Biolitec AG, AngioDynamics Inc., Albyn Medical Ltd., Ecleris S.R.L., Surkon Medical Co. Ltd., Omnitech Systems Inc., Veldana Medical SA.
North America was the largest region in the endometrial ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endometrial ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endometrial ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the endometrial ablation devices market by increasing costs of imported energy generators, catheters, electrodes, control units, and disposable components used in ablation systems. Hospitals and ambulatory surgery centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher production input costs. These tariffs are raising procedural equipment costs. However, they are also encouraging localized manufacturing, regional supplier development, and cost-optimized device innovation.
The endometrial ablation devices market research report is one of a series of new reports that provides endometrial ablation devices market statistics, including endometrial ablation devices industry global market size, regional shares, competitors with a endometrial ablation devices market share, detailed endometrial ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the endometrial ablation devices industry. This endometrial ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endometrial ablation devices encompass a range of medical tools specifically engineered for conducting procedures involving the removal or destruction of the uterine lining. These devices are instrumental in addressing gynecological conditions associated with irregular uterine bleeding.
The various categories of endometrial ablation devices exist, including hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, and others. Hysteroscopy devices encompass a suite of medical tools employed in the diagnostic and therapeutic practice of hysteroscopy. These technologies, comprising radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon procedures, and hysteroscopic ablation, cater to diverse end-users such as ambulatory surgery centers, clinics, and hospitals.
The endometrial ablation devices market consists of sales of radiofrequency ablation devices, cryoablation devices, hydrothermal devices, and microwave ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The endometrial ablation devices market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing preference for outpatient gynecological procedures, rising adoption of next-generation ablation devices, expansion of single-use medical technologies, growing focus on faster recovery treatments, increasing investments in women’s health solutions. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of radiofrequency endometrial ablation devices, growing demand for outpatient treatment options, expansion of single-use ablation technologies, enhanced focus on procedure safety and efficiency.
The rising prevalence of gynecological disorders is expected to drive the growth of the endometrial ablation devices market in the coming years. Gynecological disorders are medical conditions that affect the female reproductive system and include menstrual disorders, endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, pelvic inflammatory disease (PID), and ovarian cysts, among others. Endometrial ablation devices are used to treat these conditions by removing or destroying the uterine lining (endometrium), helping to reduce or stop heavy menstrual bleeding and manage conditions such as adenomyosis and endometrial hyperplasia. For example, in June 2023, the World Health Organization, a Switzerland-based specialized health agency dedicated to global public health, reported that PCOS affects 8-13% of women of reproductive age, with up to 70% of affected women remaining undiagnosed worldwide. Consequently, the increasing prevalence of gynecological disorders is fueling the growth of the endometrial ablation devices market.
The increasing healthcare spending is expected to drive the growth of the endometrial ablation devices market in the coming years. Healthcare expenditure refers to the total amount of financial resources allocated to healthcare services, products, and infrastructure within a specific country, region, or organization. Effective and targeted healthcare spending enhances the connectivity, safety, and overall efficiency of endometrial ablation procedures, leading to improved outcomes for women with gynecological conditions. For example, in May 2023, according to the Office for National Statistics, a UK-based government department, healthcare spending in the UK reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2022. Therefore, the rising healthcare spending is driving the growth of the endometrial ablation devices market.
Key players in the endometrial ablation devices market are also working on developing advanced solutions like field ablation systems to improve efficacy and patient comfort. A field ablation system is a medical device used to treat abnormal tissue, particularly in the heart, by applying energy (such as radiofrequency, laser, or cryotherapy) to a specific area. For instance, in January 2024, Abbott Laboratories, a US-based medical device company, launched its Volt Pulsed Field Ablation (PFA) System, marking the beginning of human trials aimed at treating atrial fibrillation (AFib). This cutting-edge technology uses pulsed field energy to selectively target heart muscle cells, minimizing collateral damage to surrounding tissues compared to traditional thermal ablation techniques. The system features a balloon-in-basket catheter design for greater precision and stability, and integrates with the EnSite X cardiac mapping platform to improve procedural accuracy. Initial trials are being conducted in Australia, with plans for global expansion, positioning Abbott as a leader in AFib treatment as demand for advanced therapies grows.
Major companies operating in the endometrial ablation devices market are Hologic Inc., Medtronic plc, Boston Scientific Corporation, Olympus Corporation, The Cooper Companies Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Richard Wolf GmbH, B. Braun Melsungen AG, Minerva Surgical Inc., AEGEA Medical Inc., Channel Medsystems Inc., Lina Medical ApS, Biolitec AG, AngioDynamics Inc., Albyn Medical Ltd., Ecleris S.R.L., Surkon Medical Co. Ltd., Omnitech Systems Inc., Veldana Medical SA.
North America was the largest region in the endometrial ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endometrial ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endometrial ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the endometrial ablation devices market by increasing costs of imported energy generators, catheters, electrodes, control units, and disposable components used in ablation systems. Hospitals and ambulatory surgery centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher production input costs. These tariffs are raising procedural equipment costs. However, they are also encouraging localized manufacturing, regional supplier development, and cost-optimized device innovation.
The endometrial ablation devices market research report is one of a series of new reports that provides endometrial ablation devices market statistics, including endometrial ablation devices industry global market size, regional shares, competitors with a endometrial ablation devices market share, detailed endometrial ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the endometrial ablation devices industry. This endometrial ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endometrial ablation devices encompass a range of medical tools specifically engineered for conducting procedures involving the removal or destruction of the uterine lining. These devices are instrumental in addressing gynecological conditions associated with irregular uterine bleeding.
The various categories of endometrial ablation devices exist, including hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, and others. Hysteroscopy devices encompass a suite of medical tools employed in the diagnostic and therapeutic practice of hysteroscopy. These technologies, comprising radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon procedures, and hysteroscopic ablation, cater to diverse end-users such as ambulatory surgery centers, clinics, and hospitals.
The endometrial ablation devices market consists of sales of radiofrequency ablation devices, cryoablation devices, hydrothermal devices, and microwave ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Endometrial Ablation Devices Market Characteristics
3. Endometrial Ablation Devices Market Supply Chain Analysis
4. Global Endometrial Ablation Devices Market Trends and Strategies
5. Endometrial Ablation Devices Market Analysis of End Use Industries
7. Global Endometrial Ablation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Endometrial Ablation Devices Total Addressable Market (TAM) Analysis for the Market
9. Endometrial Ablation Devices Market Segmentation
10. Endometrial Ablation Devices Market Regional and Country Analysis
11. Asia-Pacific Endometrial Ablation Devices Market
12. China Endometrial Ablation Devices Market
13. India Endometrial Ablation Devices Market
14. Japan Endometrial Ablation Devices Market
15. Australia Endometrial Ablation Devices Market
16. Indonesia Endometrial Ablation Devices Market
17. South Korea Endometrial Ablation Devices Market
18. Taiwan Endometrial Ablation Devices Market
19. South East Asia Endometrial Ablation Devices Market
20. Western Europe Endometrial Ablation Devices Market
21. UK Endometrial Ablation Devices Market
22. Germany Endometrial Ablation Devices Market
23. France Endometrial Ablation Devices Market
24. Italy Endometrial Ablation Devices Market
25. Spain Endometrial Ablation Devices Market
26. Eastern Europe Endometrial Ablation Devices Market
27. Russia Endometrial Ablation Devices Market
28. North America Endometrial Ablation Devices Market
29. USA Endometrial Ablation Devices Market
30. Canada Endometrial Ablation Devices Market
31. South America Endometrial Ablation Devices Market
32. Brazil Endometrial Ablation Devices Market
33. Middle East Endometrial Ablation Devices Market
34. Africa Endometrial Ablation Devices Market
36. Endometrial Ablation Devices Market Competitive Landscape and Company Profiles
37. Endometrial Ablation Devices Market Other Major and Innovative Companies
40. Endometrial Ablation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Endometrial Ablation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses endometrial ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for endometrial ablation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endometrial ablation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Hysteroscopy Devices; Thermal Balloon Ablators; Radiofrequency Endometrial Ablation Devices; Hydrothermal Ablators; Electrical Ablators; Other Device Types2) By Technology: Radiofrequency Ablation; Cryoablation; Hydrothermal Ablation; Thermal Balloon; Hysteroscopic Ablation; Other Technologies
3) By End User: Ambulatory Surgery Center; Clinic; Hospital
Subsegments:
1) By Hysteroscopy Devices: Hysteroscopic Resectoscopes; Operative Hysteroscopes2) By Thermal Balloon Ablators: Single-Use Balloon Catheters; Multi-Use Balloon Systems
3) By Radiofrequency Endometrial Ablation Devices: Bipolar Rf Systems; Monopolar Rf Systems
4) By Hydrothermal Ablators: Heated Saline Infusion Systems; Water-Based Ablation Devices
5) By Electrical Ablators: Electrosurgical Systems; Electrical Current-Based Devices
6) By Other Device Types: Cryoablation Devices; Microwave Endometrial Ablation Systems; Laser Ablation Devices
Companies Mentioned: Hologic Inc.; Medtronic plc; Boston Scientific Corporation; Olympus Corporation; The Cooper Companies Inc.; Cook Medical Incorporated; Karl Storz SE & Co. KG; Richard Wolf GmbH; B. Braun Melsungen AG; Minerva Surgical Inc.; AEGEA Medical Inc.; Channel Medsystems Inc.; Lina Medical ApS; Biolitec AG; AngioDynamics Inc.; Albyn Medical Ltd.; Ecleris S.R.L.; Surkon Medical Co. Ltd.; Omnitech Systems Inc.; Veldana Medical SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Endometrial Ablation Devices market report include:- Hologic Inc.
- Medtronic plc
- Boston Scientific Corporation
- Olympus Corporation
- The Cooper Companies Inc.
- Cook Medical Incorporated
- Karl Storz SE & Co. KG
- Richard Wolf GmbH
- B. Braun Melsungen AG
- Minerva Surgical Inc.
- AEGEA Medical Inc.
- Channel Medsystems Inc.
- Lina Medical ApS
- Biolitec AG
- AngioDynamics Inc.
- Albyn Medical Ltd.
- Ecleris S.R.L.
- Surkon Medical Co. Ltd.
- Omnitech Systems Inc.
- Veldana Medical SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.14 Billion |
| Forecasted Market Value ( USD | $ 5.55 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
